Mediwhale
  • About
    • Founder Story
    • Dr. Noon
    • Leadership
    • Journey
  • Products
    • Dr. Noon CVD
    • Dr. Noon CKD
    • Dr. Noon Fundus
    • Dr. Noon Age
  • Resources
    • Publications
    • English News
    • Korean News
  • Careers
  • Contact
  • ko_KRKO
Select Page

Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management

Sep 26, 2024 | AP

APㅣ Sep. 26 2024 SEOUL, South Korea, Sept. 25, 2024 /PRNewswire/ — Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of...

Mediwhale Brings AI-empowered Diagnostic Retina Scans to the United States to Help Prevent Heart and Kidney Diseases

Dec 8, 2022 | AP

AP | November 10, 2022 The South Korean, AI diagnostic company aims for FDA approvals to increase non-invasive, early detection to save lives “Our products are non-invasive, which means patients avoid radiation risk from CT scans and the inconvenience and discomfort...

Let’s build the future of digital healthcare together

Connect with us

ABOUT

Founder Story

Dr. Noon

Leadership

Journey

PRODUCTS

Dr. Noon CVD

Dr. Noon CKD

Dr. Noon Fundus

Dr. Noon Age

RESOURCES

Publications

English News

Korean News

CAREERS

CONTACT

NEWSLETTER

FOLLOW US

  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2023 Mediwhale Inc. All rights reserved.      Privacy Policy  |  Terms of Use